SCHEMBL6987997

SCHEMBL6987997

CCOC(=O)C1=CCCCO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
CA12 O43570 5/20 0.41
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA7 P43166 5/20 0.41
CA9 Q16790 5/20 0.41
CA14 Q9ULX7 5/20 0.41
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
TSHR P16473 2/20 0.40
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.37
RAB9A P51151 1/20 0.37
CYP1A2 P05177 2/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915033 0.89 L3MBTL1 (0.44) L3MBTL1CA12CA1CA2CA7
SCHEMBL7749784 0.80 ALDH1A1 (0.38) CA12CA1CA2CA7CA9
SCHEMBL6439301 0.74 CA12 (0.47) CA12CA1CA2CA7CA9
SCHEMBL11126262 0.74
SCHEMBL13893803 0.73 MGAM (0.44) L3MBTL1TSHRALDH1A1KDM4ELMNA
SCHEMBL819891 0.72 TSHR (0.45) CA12CA1CA2CA7CA9
SCHEMBL3526544 0.71
SCHEMBL340678 0.71 HDAC4 (0.47) CA12CA1CA2CA7CA9
SCHEMBL6612795 0.70 MEN1 (0.41) L3MBTL1CA12CA1CA2CA7
SCHEMBL19182614 0.70 CYP3A4 (0.32) L3MBTL1ALDH1A1KDM4ELMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296978-A2 N-UREIDOHETEROCYCLOAKLYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2003-04-02 EP disclosed
WO-2002002525-A2 N-UREIDOHETEROCYCLOAKLYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-01-10 WO disclosed